A Phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson disease(STEADY-PD III): Baseline characteristics and study update
Objective: To evaluate the efficacy of isradipine 10 mg daily on Parkinson disease (PD) disability. Background: Isradipine, a dihydropyridine calcium channel antagonist with excellent penetration…Objective assessment of Parkinson’s disease motor symptoms during leg agility test using motion sensors
Objective: To develop and evaluate machine learning methods for assessment of Parkinson’s disease (PD) motor symptoms using leg agility (LA) data collected with motion sensors…Validity And Reliability Of Nineteen-Item Wearing-Off Questionnaire In Turkish Patients
Objective: To conduct the validity and reliability study of the Turkish version of nineteen-item wearing-off (WO19)questionnaire. Background: Wearing-off(WO)is probably the most frequent motor complication of…Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial
Objective: To investigate whether women and men with Parkinson's disease (PD) may differ in their biochemical and clinical responses to long-term treatment with urate-elevating inosine.…Prospective, home-based assessment of motor symptoms in Parkinson’s disease by mean of the Sleep Fit app: A potential new clinical approach
Objective: To investigate the correspondence between subjective data on motor symptoms prospectively collected at home and retrospective, subjective data assessed by structured interview in patients…Pediatric Tics and DCD: Motor Network Disorders?
Objective: To characterize and quantify pediatric tics and DCD according to specific movement disorder features. Background: Until now, it has been impossible to attribute the…Motivators, Barriers and Clinical Correlates of Physical Activity in Parkinson Disease
Objective: To characterize physical activity levels as well as barriers and motivators for exercise in US military Veterans with Parkinson disease (PD). Background: Physical activity…Assessments of Movement Disorder Symptoms and Functional Impacts in Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Objective: To identify Clinical Outcome Assessments (COAs) appropriate for the evaluation of paroxysmal movement disorder symptoms and functional impact in Glut1 DS. Background: Glut1 DS…Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)
Objective: Test if differential item functioning (DIF) due to gender, age, race/ethnicity or education level is present in UDysRS items. Background: Testing a rating…Using measurements from wearable sensors for automatic scoring of Parkinson’s disease motor states
Objective: The aim of this study was to investigate the concurrent validity of an objective gait measure for assessment of motor states in advanced Parkinson’s…
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 35
- Next Page »